Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · Real-Time Price · USD

9.90

-0.38 (-3.70%)

At close: Jun 2, 2026, 4:00 PM EDT

9.70

-0.20 (-2.02%)

After-hours: Jun 2, 2026, 5:25 PM EDT

Atara Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.36	8.48	25.03	25.84	92.94	106.08
Short-Term Investments	-	-	17.47	25.88	149.88	264.98
Cash & Short-Term Investments	8.36	8.48	42.5	51.73	242.82	371.07
Cash Growth	-39.60%	-80.04%	-17.84%	-78.70%	-34.56%	-25.88%
Accounts Receivable	-	1.25	1.48	34.11	40.22	0.99
Inventory	-	-	10.66	9.71	1.59	-
Other Current Assets	3.81	2.48	10.26	6.33	10.45	12.57
Total Current Assets	12.17	12.21	64.89	101.87	295.08	384.62
Net Property, Plant & Equipment	6.93	7.14	41.1	58.79	74.32	79.94
Other Long-Term Assets	0.89	0.89	3.1	4.84	7.02	3.57
Total Assets	20	20.24	109.1	165.5	376.42	468.13
Accounts Payable	0.64	0.13	4.37	3.68	6.87	17.37
Accrued Expenses	0.67	1.35	14.57	28.88	42.65	38.6
Unearned Revenue	0.68	0.72	95.09	77.83	8	40.76
Other Current Liabilities	3.65	12.73	20.54	31.83	21.39	9.06
Total Current Liabilities	5.65	14.92	134.57	142.23	78.92	105.79
Long-Term Leases	9.08	9.35	29.91	45.69	58.06	25.52
Other Long-Term Liabilities	42.59	34.47	41.89	76.82	112.8	57.21
Total Long-Term Liabilities	51.66	43.82	71.81	122.51	170.86	82.73
Total Liabilities	57.31	58.74	206.38	264.74	249.78	188.51
Common Stock	0	0	0	-	0.01	0.01
Additional Paid-in Capital	1,989	1,983	1,957	1,870	1,822	1,745
Accumulated Other Comprehensive Income	-	0	0.01	-0.2	-2.07	-0.37
Retained Earnings	-2,026	-2,022	-2,055	-1,969	-1,693	-1,465
Shareholders' Equity	-37.31	-38.5	-97.28	-99.23	126.64	279.61
Total Liabilities & Equity	20	20.24	109.1	165.5	376.42	468.13
Total Debt	9.08	9.35	29.91	45.69	58.06	25.52
Net Cash (Debt)	-0.72	-0.87	12.58	6.03	184.76	345.55
Net Cash Growth	-	-	108.59%	-96.73%	-46.53%	-29.13%
Net Cash Per Share	-0.05	-0.07	1.68	1.42	45.29	92.22
Book Value	-37.31	-38.5	-97.28	-99.23	126.64	279.61
Book Value Per Share	-2.75	-3.03	-12.99	-23.43	31.04	74.63
Tangible Book Value	-37.31	-38.5	-97.28	-99.23	126.64	279.61
Tangible Book Value Per Share	-2.75	-3.03	-12.99	-23.43	31.04	74.63

SEC Filings: 10-K · 10-Q